Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
Key Information
Due Date: September 7, 2026
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia" grant (R21 Clinical Trial Optional) is a funding opportunity aimed at encouraging research studies that improve our understanding of neuropsychiatric symptoms in people with Alzheimer's disease and related dementias. This research seeks to explore the mechanisms behind these symptoms, focusing on both biobehavioral and neurobiological pathways. Through the findings, the hope is to gain a deeper understanding that could contribute to identifying new therapeutic targets. These targets could lead to the development of treatments and preventative measures for the neuropsychiatric symptoms commonly experienced by those with Alzheimer's and related dementias.
Show More
Key Dates
Open Date: June 14, 2023
Application Due Date: September 7, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses